Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Targeted quantification assays for DNA repair and handling proteins and interactions in Huntington's disease models

Greco TM, Hutton JE, Justice JL, Reed TJ, Vogt TF, Prasad BC, Cristea IM.

bioRxiv [Preprint]. 2026 Jul 29:2026.07.28.741339. doi: 10.64898/2026.07.28.741339.

Unscheduled DNA synthesis reveals a DNA repair hotspot and biomarker of somatic instability at the expanded-CAG repeat tract in the huntingtin gene

Fernandez JP, Gärtner A, Perez-Perez J, Cumming SA, Feng J, van Belois K, He K, Yang D, Castells-Esteve C, Bergé-Gardeñes M, Bergander AL, Lubieniecki KP, Miclăuș M, Fissolo N, Comabella M, Vogt A, Gebauer L, Cavaleri F, Voelkner C, Illarionova A, Limbani H, Marke G, Chen RZ, Prasad BC, Vogt TF, Reid DA, Pinto RM, Podlesniy P, Kulisevsky J, Balmus G, Nguyen HP, Pouladi MA, Monckton DG, Brito V, Beuzer P.

bioRxiv [Preprint]. 2026 Jul 29:2026.07.29.741355. doi: 10.64898/2026.07.29.741355.

HSF1 controls transcriptional programs that establish thalamostriatal shaft synaptic architecture and preserve cognitive flexibility

Rozema NB, Zarate N, Mansky R, Gu P, Gerlach K, Bhowmik A, Cho JH, Zhang Y, Hamid A, Graves SM, Gomez-Pastor R.

bioRxiv [Preprint]. 2026 Aug 6:2026.08.03.742053. doi: 10.64898/2026.08.03.742053.

Rheumatic fever and rheumatic heart disease: updates for clinical practice

Noonan S, Marangou J, Currie BJ, Wade V, Ralph AP.

Aust Prescr. 2026 Aug;49(4):131-137. doi: 10.18773/austprescr.2026.028.

Targeting soluble misfolded oligomers in anti-amyloid research

Vosbein P, Mao H, Lou C.

Nat Rev Chem. 2026 Aug 20. doi: 10.1038/s41570-026-00867-y. Online ahead of print.

RNA interference (RNA)-based therapeutics for treating neurodegenerative diseases

Mahjoubin-Tehran M, Sahebkar A.

Neurodegener Dis Manag. 2026 Aug 21:1-3. doi: 10.1080/17582024.2026.2722300. Online ahead of print.

The Role of MicroRNA in Diagnosis of Huntington's Disease: A Systematic Review

Khan S, Thalib HI, Khan TN, Alawi KM, Alabdrabalrasol ZH, Hassan FE.

Mol Neurobiol. 2026 Aug 22;63(1):850. doi: 10.1007/s12035-026-06143-w.

Dysfunction of Primary Cilium in Huntington's Disease: How Mutant Huntingtin Disrupts This Cellular Signaling Hub

Churkina AS, Shakhov AS, Alieva IB.

Biochemistry (Mosc). 2026 Jul;91(7):1137-1156. doi: 10.1134/S0006297926601590.

Huntingtin, signaling endosomes and neuronal survival in health and Huntington disease

Saliba M, Saudou F, Scaramuzzino C.

J Huntingtons Dis. 2026 Aug 24:18796397261480227. doi: 10.1177/18796397261480227. Online ahead of print.

Protein Kinase C-delta (PKCδ) in Neurodegeneration and Cerebral Ischemia: Molecular Mechanisms and Therapeutic Implications

Hsieh YH, Lee IY, Lien Y, Lye LF, Ou YC, Yang DI.

Cell Biochem Biophys. 2026 Aug 24. doi: 10.1007/s12013-026-02125-w. Online ahead of print.

Neuronal Antibodies in Patients With Atypical Parkinsonism

Kerstens J, Dopper EGP, Kaat LD, Meeter LH, De Graaff E, de Vries JM, Crijnen YS, Van Steenhoven RW, Veenbergen S, Fransen N, Franken SC, Nagtzaam MMP, Erdag Turgeon E, Seelaar H, Van Swieten JC, Hoogland MA, Verbeek MM, Bloem BR, Sillevis Smitt PAE, Boon AJW, van de Warrenburg BPC, Titulaer MJ.

Neurol Neuroimmunol Neuroinflamm. 2026 Sep;13(5):e200631. doi: 10.1212/NXI.0000000000200631. Epub 2026 Aug 24.

Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders

Aldaghi FS, Siahpoosh Z, Salehi Z, Mashayekhi F, Sohrabnezhad S.

Brain Behav. 2026 Aug;16(8):e71615. doi: 10.1002/brb3.71615.

Segmental brainstem myoclonus in ADCK3-Related ataxia: A novel phenomenon?

Colona VL, Garone G, Nicita F, Travaglini L, Pro S, Rossi-Espagnet MC, Piluso A, Bisozzi E, Lettori D, Bertini E, Vasco G.

Parkinsonism Relat Disord. 2026 Jul;148:107262. doi: 10.1016/j.parkreldis.2025.107262. Epub 2025 Jan 4.

The agreement between face-to-face and tele-assessment of ataxia severity scales in multiple sclerosis patients with ataxia

Ozvar Senoz GB, Ayvat F, Ayvat E, Kilinc M.

J Telemed Telecare. 2026 Jun;32(5):479-490. doi: 10.1177/1357633X251369245. Epub 2025 Aug 19.

Atypical features including acquired oculomotor apraxia in C9orf72-associated familial primary lateral sclerosis

Hostetler N, Zakutney S, Pringle CE, Zwicker J, Breiner A.

J Neuromuscul Dis. 2026 Jul;13(4):808-816. doi: 10.1177/22143602251380427. Epub 2025 Sep 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias